Cargando…
Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSCC) is a leading cause of morbidity and mortality globally. Despite significant advances in well-established treatment techniques, prognosis for advanced-stage HNSCC remains poor. Recent, accumulating evidence supports a role for immunotherapy in HNSCC treat...
Autores principales: | Runnels, Juliana, Bloom, Julie R., Hsieh, Kristin, Dickstein, Daniel R., Shi, Yuhao, Jones, Brianna M., Lehrer, Eric J., Bakst, Richard L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452591/ https://www.ncbi.nlm.nih.gov/pubmed/37626594 http://dx.doi.org/10.3390/biomedicines11082097 |
Ejemplares similares
-
Radiotherapy and Immunotherapy in Lung Cancer
por: Hsieh, Kristin, et al.
Publicado: (2023) -
Management of Older Adults with Locally Advanced Head and Neck Cancer
por: Dickstein, Daniel R., et al.
Publicado: (2022) -
Moving beyond Definitive Therapy: Increasing Physical Activity in Survivors of Cancers of the Head and Neck
por: Nehlsen, Anthony D., et al.
Publicado: (2022) -
Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer
por: Dickstein, Daniel R, et al.
Publicado: (2023) -
Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer
por: Plavc, Gaber, et al.
Publicado: (2020)